We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
-3%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$12.4B
AUM Growth
-$1.17B
(-8.6%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
13.34%
Holding
358
New
14
Increased
143
Reduced
171
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$83.7M |
| 2 |
Humana
HUM
|
+$52.3M |
| 3 |
QLGC
QLOGIC CORP
QLGC
|
+$49.1M |
| 4 |
Designer Brands
DBI
|
+$45.5M |
| 5 |
Puma Biotechnology
PBYI
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$97.1M |
| 3 |
Aptiv
APTV
|
+$82.1M |
| 4 |
ATML
ATMEL CORP
ATML
|
+$66M |
| 5 |
ITMN
INTERMUNE INC
ITMN
|
+$57.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.8% |
| 2 | Technology | 18.17% |
| 3 | Healthcare | 11.61% |
| 4 | Financials | 11.28% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
AbbVie
ABBV
$465B
| $3.07M | 0.02% |
53,146
+630
| +1% | +$35K |
|
|
P
302
DELISTED
Pandora Media Inc
P
| $2.72M | 0.02% |
112,478
+103,229
| +1,116% | +$2.74M |
|
303
Teva Pharmaceuticals
TEVA
$40.4B
| $2.64M | 0.02% |
49,086
+560
| +1% | +$29.7K |
|
|
GNC
304
DELISTED
GNC Holdings, Inc.
GNC
| $2.44M | 0.02% |
62,882
-5,743
| -8% | -$209K |
|
305
Insperity
NSP
$2.03B
| $2.17M | 0.02% |
158,542
-1,657,974
| -91% | -$25.2M |
|
|
IL
306
DELISTED
IntraLinks Holdings Inc.
IL
| $2.08M | 0.02% |
256,514
-83,506
| -25% | -$702K |
|
|
XONE
307
DELISTED
The ExOne Company
XONE
| $1.83M | 0.01% |
87,569
-197,133
| -69% | -$6.02M |
|
|
XENT
308
DELISTED
Intersect ENT, Inc
XENT
| $1.65M | 0.01% |
+106,590
| New | +$1.6M |
|
|
ELOS
309
DELISTED
Syneron Medical Ltd
ELOS
| $1.46M | 0.01% |
145,511
-60,839
| -29% | -$619K |
|
|
SEAC
310
DELISTED
Seachange International Inc
SEAC
| $552K | ﹤0.01% |
3,967
-15
| -0.4% | -$2.28K |
|
|
RTI
311
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $504K | ﹤0.01% |
20,427
-156,275
| -88% | -$4.23M |
|
312
RE/MAX Holdings
RMAX
$198M
| $500K | ﹤0.01% |
16,819
-168
| -1% | -$5K |
|
|
313
Aptiv
APTV
$12.3B
| $283K | ﹤0.01% |
4,607
-1,198,840
| -100% | -$82.1M |
|
|
SGEN
314
DELISTED
Seagen Inc. Common Stock
SGEN
| $215K | ﹤0.01% |
5,789
-149
| -3% | -$5.86K |
|
315
Fidelity National Information Services
FIS
$24.2B
| $50K | ﹤0.01% |
886
| – | – |
|
|
QVCGA
316
DELISTED
QVC Group Inc Series A
QVCGA
| $44K | ﹤0.01% |
37
| – | – |
|
317
Weyerhaeuser
WY
$17.6B
| $41K | ﹤0.01% |
1,294
-5,358
| -81% | -$176K |
|
318
DaVita
DVA
$15.5B
| $36K | ﹤0.01% |
494
| – | – |
|
319
Micron Technology
MU
$835B
| $35K | ﹤0.01% |
1,010
| – | – |
|
320
Cigna
CI
$78.4B
| $34K | ﹤0.01% |
371
| – | – |
|
321
RLJ Lodging Trust
RLJ
$1.88B
| $34K | ﹤0.01% |
1,188
| – | – |
|
322
American Water Works
AWK
$27B
| $33K | ﹤0.01% |
679
+90
| +15% | +$4.4K |
|
323
Edison International
EIX
$30.3B
| $32K | ﹤0.01% |
580
| – | – |
|
|
MFA
324
MFA Financial
MFA
$932M
| $32K | ﹤0.01% |
1,031
| – | – |
|
325
Enerpac Tool Group
EPAC
$1.86B
| $31K | ﹤0.01% |
1,020
+210
| +26% | +$6.94K |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Frontier Capital Management held 358 positions worth $12.4B, down 8.6% from $13.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Frontier Capital Management withdrew a net $425M in Q3 2014, closing 11 positions and reducing 171 holdings. Its most notable exit was INTERMUNE INC, an estimated $57.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Frontier Capital Management opened a new position in Humana worth $53.6M.
- Frontier Capital Management's largest Q3 2014 buy was Humana: 411,770 shares worth $53.6M.
- Frontier Capital Management added most to Centene in Q3 2014, an estimated $83.7M increase.
- Frontier Capital Management's biggest Q3 2014 reduction was Allergan plc, cutting an estimated $104M.
- Frontier Capital Management fully exited INTERMUNE INC in Q3 2014, selling an estimated $57.5M.
- Frontier Capital Management's ten largest holdings make up 13% of its $12.4B portfolio in Q3 2014.
- Frontier Capital Management opened 14 new positions and closed 11 in Q3 2014.
- Frontier Capital Management's portfolio value fell 8.6% quarter-over-quarter to $12.4B.
Based on Frontier Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.